PDK2 and Alzheimer disease: We also elucidated that as a potential novel compound for treating AD, COR promotes glycolysis and OXPHOS to drive metabolic reprogramming by dual‐targeting HKII and PDK2 while coupling with MG‐M2 polarization to exert anti‐AD effects.